Answers are grounded in this paper and cite their sources.
BACKGROUNDCurrent evidence regarding the microbiome detected in endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) specimens from unresectable pancreatic cancer is limited, partly because these specimens are low-biomass and susceptible to contamination. AIMTo evaluate the temporal association between echoendoscope reprocessing status, including monthly ethylene oxide (ETO) gas sterilization, and microbiome profiles detected in EUS-FNB specimens from unresectable pancreatic adenocarcinoma. METHODSFrom March 2021 to March 2023, patients with suspected unresectable pancreatic adenocarcinoma were prospectively enrolled.Patients were categorized into five sequential groups according to echoendoscope reprocessing status: Group 1, high-level disinfection (HLD) plus monthly ETO; groups 2 and 3, HLD only during ETO suspension; and groups 4 and 5, HLD plus resumed monthly ETO.Microbiome profiles were characterized using 16S ribosomal RNA gene sequencing.Alpha diversity, beta diversity, and taxonomic composition were evaluated as primary outcomes.Salivary microbiome analyses were performed in group 5, and metastatic-status comparisons were considered exploratory. RESULTSAmong 100 enrolled patients, 87 with pancreatic adenocarcinoma were analyzed.Alpha and beta diversity differed across the five sequential reprocessing periods (all P < 0.001).Proteobacteria, particularly Pseudomonas, showed increased relative abundance during the HLD-only periods and decreased relative abundance following ETO reinstatement.In Core Tip: The intratumoral microbiome plays a significant role in the development and progression of pancreatic cancer.However, studies utilizing endoscopic ultrasoundguided fine-needle biopsy (EUS-FNB) specimens in cases of unresectable disease have demonstrated heterogeneous and inconsistent findings, highlighting notable challenges with contamination control in low-biomass specimens.Ethylene oxide gas sterilization significantly impacted the intratumoral microbiome profiles derived from EUS-FNB specimens in patients with unresectable pancreatic cancer.Exploratory analyses according to metastatic status did not identify significant differences in conventional diversity measures, genus-level differential abundance, or PICRUSt2-predicted MetaCyc, KEGG Ortholog, or Enzyme Commission features after multiple-testing correction.Descriptive network findings remain hypothesis-generating.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: